Alaa Alsebahi
Papers
1
Total Citations
176
H-Index
1
About
Alaa Alsebahi is a pioneering researcher in the field of microphysiological systems, with a primary focus on developing advanced organ-on-a-chip platforms for drug toxicity screening. Their most significant contribution is the development and validation of the OrganoPlate LiverTox™, a 3D microfluidic liver model that enables high-throughput hepatotoxicity testing. This groundbreaking work, published in 2021 and cited 176 times, demonstrates the successful integration of induced pluripotent stem cell (iPSC)-derived hepatocytes into a microfluidic platform, creating a more physiologically relevant alternative to traditional 2D culture systems. Alsebahi’s research addresses a critical bottleneck in drug development by providing a scalable, automated solution for compound toxicity screening that better predicts human liver responses. Their work represents a major advancement in reducing animal testing and improving the accuracy of preclinical drug safety assessments. By combining stem cell technology with microfluidics, Alsebahi has helped bridge the gap between in vitro models and in vivo human physiology, making a lasting impact on the fields of tissue engineering, toxicology, and pharmaceutical development.
Research Focus
Key Achievements
Top Papers
- 1